137 related articles for article (PubMed ID: 36906888)
1. Proteinuria in thrombotic microangiopathy is associated with partial podocytopathy.
Moore M; Afolayan-Oloye O; Kroneman O; Li W; Kanaan HD; Zhang PL
Ultrastruct Pathol; 2023 May; 47(3):219-226. PubMed ID: 36906888
[TBL] [Abstract][Full Text] [Related]
2. Podocyte Involvement in Renal Thrombotic Microangiopathy: A Clinicopathological Study.
Hu YF; Tan Y; Yu XJ; Wang H; Wang SX; Yu F; Zhao MH
Am J Nephrol; 2020; 51(9):752-760. PubMed ID: 32862175
[TBL] [Abstract][Full Text] [Related]
3. VEGF-VEGFR2 inhibitor-associated hyaline occlusive glomerular microangiopathy: a Japanese single-center experience.
Ozawa M; Ohtani H; Komatsuda A; Wakui H; Takahashi N
Clin Exp Nephrol; 2021 Nov; 25(11):1193-1202. PubMed ID: 34115234
[TBL] [Abstract][Full Text] [Related]
4. Role of progenitor cell marker CD133 in supporting diagnosis of collapsing glomerulopathy.
Xiao AY; Kanaan HD; Lai Z; Li W; Zhang PL
Int Urol Nephrol; 2022 Aug; 54(8):1957-1968. PubMed ID: 34978023
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features and outcomes of SLE patients with renal injury characterised by thrombotic microangiopathy.
Chen W; Liang S; Zuo K; Yang L; Zeng C; Hu W
Clin Rheumatol; 2021 Jul; 40(7):2735-2743. PubMed ID: 33543375
[TBL] [Abstract][Full Text] [Related]
6. Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma.
Hobeika L; Self SE; Velez JC
BMC Nephrol; 2014 Sep; 15():156. PubMed ID: 25267524
[TBL] [Abstract][Full Text] [Related]
7. The Detection of Urinary Podocytes from Drug-Induced Glomerular Thrombotic Microangiopathy in Advanced Cancer Patients.
Usui J; Yokoyama C; Hagiwara M; Hirayasu K; Kojima T; Yoshino T; Nishiyama H; Hara M; Yamagata K
Clin Lab; 2016 Dec; 62(12):2413-2417. PubMed ID: 28164557
[TBL] [Abstract][Full Text] [Related]
8. Pathologic Correlation with Renal Dysfunction after Intravitreal Injections of Vascular Endothelial Growth Factor Antagonists.
Zhang PL; Raza S; Li W; Kanaan HD
Ann Clin Lab Sci; 2021 Nov; 51(6):875-882. PubMed ID: 34921042
[TBL] [Abstract][Full Text] [Related]
9. Two cases of idiopathic steroid-resistant nephrotic syndrome complicated with thrombotic microangiopathy.
Nishi K; Sato M; Ogura M; Okutsu M; Ishikura K; Kamei K
BMC Nephrol; 2020 Aug; 21(1):323. PubMed ID: 32746791
[TBL] [Abstract][Full Text] [Related]
10. Kidney thrombotic microangiopathy in lupus nephritis: Impact on treatment and prognosis.
Massicotte-Azarniouch D; Kotzen E; Todd S; Hu Y; Hogan SL; Jain K
Lupus; 2022 Sep; 31(10):1175-1185. PubMed ID: 35650019
[TBL] [Abstract][Full Text] [Related]
11. Association of glomerular podocytopathy and nephrotic proteinuria in mesangial lupus nephritis.
Han TS; Schwartz MM; Lewis EJ
Lupus; 2006; 15(2):71-5. PubMed ID: 16539276
[TBL] [Abstract][Full Text] [Related]
12. Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report.
Yamada R; Okawa T; Matsuo K; Suzuki M; Mori N; Mori K
BMC Nephrol; 2019 Jan; 20(1):14. PubMed ID: 30634936
[TBL] [Abstract][Full Text] [Related]
13. A case of ramucirumab-induced renal failure with nephrotic-range proteinuria and its pathological findings.
Nakano Y; Kumagai J; Nagahama K; Fujisawa H
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33653851
[TBL] [Abstract][Full Text] [Related]
14. A nationwide cross-sectional analysis of thrombotic microangiopathy in the Japan Renal Biopsy Registry (J-RBR).
Katsuno T; Ito Y; Kagami S; Kitamura H; Maruyama S; Shimizu A; Sugiyama H; Sato H; Yokoyama H; Kashihara N
Clin Exp Nephrol; 2020 Sep; 24(9):789-797. PubMed ID: 32415379
[TBL] [Abstract][Full Text] [Related]
15. [A case of thrombotic microangiopathy with glomerular subendothelial IgA deposition due to bevacizumab].
Tomita M; Ochiai M; Shu S; Yamauchi Y; Shihara H; Ogata A; Fujisawa N; Yanai Y; Kamata T; Iehara N
Nihon Jinzo Gakkai Shi; 2014; 56(5):612-7. PubMed ID: 25130034
[TBL] [Abstract][Full Text] [Related]
16. Renal thrombotic microangiopathy in mice with combined deletion of endocytic recycling regulators EHD3 and EHD4.
George M; Rainey MA; Naramura M; Foster KW; Holzapfel MS; Willoughby LL; Ying G; Goswami RM; Gurumurthy CB; Band V; Satchell SC; Band H
PLoS One; 2011 Mar; 6(3):e17838. PubMed ID: 21408024
[TBL] [Abstract][Full Text] [Related]
17. Correlation of proteinuria with podocyte foot process effacement in IgA nephropathy: an ultrastructural study.
Tewari R; Nada R; Rayat CS; Boruah D; Dudeja P; Joshi K; Sakhuja V
Ultrastruct Pathol; 2015 Apr; 39(2):147-51. PubMed ID: 25268180
[TBL] [Abstract][Full Text] [Related]
18. Association of vascular endothelial growth factor and renal thrombotic microangiopathy-like lesions in patients with Castleman's disease.
Sun PP; Yu XJ; Wang SX; Zhou XJ; Qu L; Zhang F; Ma YY; Liu G; Yang L
Nephrology (Carlton); 2020 Feb; 25(2):125-134. PubMed ID: 31264312
[TBL] [Abstract][Full Text] [Related]
19. A Case of the nephrotic syndrome in bone marrow transplantation recipient, histologically showing overlapped glomerular lesions of thrombotic microangiopathy and membranous nephropathy.
Masuzawa N; Nishimura A; Kitani T; Tamagaki K; Sugitani M; Nagoshi H; Kuroda J; Konishi E
Pathol Int; 2017 Dec; 67(12):620-625. PubMed ID: 28940837
[TBL] [Abstract][Full Text] [Related]
20. Proteinuria with and without renal glomerular podocyte effacement.
Kalluri R
J Am Soc Nephrol; 2006 Sep; 17(9):2383-9. PubMed ID: 16914535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
